Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 26(22): 5418-5428, 2016 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-27789137

RESUMEN

N,N-Disubstituted benzylamine derivatives have been identified as CXCR3 antagonists. Compounds were optimized to improve affinity and selectivity, to increase metabolic stability in human and mouse liver microsomes, to increase Caco-2 permeability. Optimization was supported by monitoring physico-chemical properties using both experimental and computational means. Several compounds with double-digit nanomolar CXCR3 affinity, favorable selectivity, microsomal stability, Caco-2 permeability and human hepatocyte clearance have been identified.


Asunto(s)
Bencilaminas/química , Bencilaminas/farmacología , Receptores CXCR3/antagonistas & inhibidores , Receptores CXCR3/metabolismo , Animales , Bencilaminas/farmacocinética , Células CACO-2 , Humanos , Ratones , Microsomas Hepáticos/metabolismo , Modelos Moleculares , Relación Estructura-Actividad
2.
Bioorg Med Chem Lett ; 26(22): 5429-5437, 2016 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-27789141

RESUMEN

A new series of beta amino acids, which act as CXCR3 antagonists, has been identified. The formerly optimized N,N-disubstituted benzylamine derivatives with carboxylic acid function on the N-atom was used as starting point and compounds with carboxyl function not attached to the N-atom were investigated. Affinity, metabolic stability in human and mouse liver microsomes and Caco-2 permeability were optimized. Compounds with double-digit nanomolar CXCR3 affinity, favourable microsomal stability and Caco-2 permeability have been identified.


Asunto(s)
Aminoácidos/química , Aminoácidos/farmacología , Bencilaminas/química , Bencilaminas/farmacología , Receptores CXCR3/antagonistas & inhibidores , Aminoácidos/farmacocinética , Animales , Bencilaminas/farmacocinética , Células CACO-2 , Descubrimiento de Drogas , Humanos , Ratones , Microsomas Hepáticos/metabolismo , Receptores CXCR3/metabolismo
3.
Eur J Pharmacol ; 449(1-2): 55-60, 2002 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-12163106

RESUMEN

The effect of the isoquinoline derivative, drotaverine on the specific binding of [(3)H]nitrendipine and [(3)H]diltiazem to pregnant rat uterine membranes was examined. Drotaverine inhibited the specific [(3)H]nitrendipine and [(3)H]diltiazem bindings with IC(50) values of 5.6 and 2.6 microM, respectively. Saturation studies showed that diltiazem caused a significant increase in the maximum binding density without changing the K(D) of [(3)H]nitrendipine while drotaverine increased both the K(D) and the B(max) of [3H]nitrendipine. The dissociation kinetics of both [3H]nitrendipine and [(3)H]diltiazem were accelerated by drotaverine. These results suggest that drotaverine has a negative allosteric interaction with the binding sites for 1,4-dihydropyridines and 1,5-benzothiazepines on the L-type Ca(2+) channel in pregnant rat uterine membranes, which may have implications as to the potential usefulness of this drug in aiding child delivery.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/efectos de los fármacos , Papaverina/análogos & derivados , Papaverina/farmacología , Preñez/fisiología , Útero/metabolismo , 3',5'-AMP Cíclico Fosfodiesterasas/antagonistas & inhibidores , Animales , Unión Competitiva/efectos de los fármacos , Bloqueadores de los Canales de Calcio/metabolismo , Canales de Calcio Tipo L/metabolismo , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 , Diltiazem/metabolismo , Diltiazem/farmacología , Femenino , Semivida , Técnicas In Vitro , Cinética , Membranas/efectos de los fármacos , Membranas/metabolismo , Nitrendipino/metabolismo , Nitrendipino/farmacología , Papaverina/metabolismo , Parasimpatolíticos/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Embarazo , Ensayo de Unión Radioligante , Ratas , Ratas Sprague-Dawley , Útero/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...